Acquisition Opportunity Potential upsell or partnership angle with Revelation Pharma following the Jan 2025 acquisition, focusing on Cascade’s ENT, animal health, and personalized compounding capabilities to expand 503A/503B service offerings.

Expansion Readiness Leverage Cascade’s niche specialties (Urology and Men’s Health, Hormone Replacement, Veterinary Medicine) to target fast-growing segments within Revelation Pharma’s network and to scale personalized therapies across new markets.

Technology Enablement Highlight the already adopted tech stack (AWS, WordPress, Magento) as a foundation for secure e-commerce, patient education portals, and streamlined order management to support integrated pharmacy services post-acquisition.

Med Specialties Market Cascade’s focus areas to pharma distributors and clinics seeking specialized compounding services for dermatology, sinus health, and hormone therapies to diversify product offerings and improve patient outcomes.

Financial & Scale With revenue in the 10–25 million range and a lean team, present opportunities for cost-effective integration, cross-sell of compounding formulations, and accelerated revenue synergies within a larger pharmaceutical network.